Vijay Kumar
Stock Analyst at Evercore ISI Group
(2.21)
# 2,470
Out of 4,810 analysts
195
Total ratings
38.39%
Success rate
-5.8%
Average return
Main Sectors:
Stocks Rated by Vijay Kumar
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| EW Edwards Lifesciences | Maintains: In-Line | $75 → $73 | $70.70 | +3.26% | 11 | Feb 12, 2025 | |
| MTD Mettler-Toledo International | Maintains: Outperform | $1,450 → $1,475 | $1,055.50 | +39.74% | 9 | Feb 10, 2025 | |
| HOLX Hologic | Maintains: In-Line | $76 → $73 | $57.90 | +26.08% | 13 | Feb 6, 2025 | |
| AZTA Azenta | Maintains: In-Line | $50 → $52 | $26.62 | +95.34% | 6 | Feb 6, 2025 | |
| JBHT J.B. Hunt Transport Services | Maintains: Outperform | $207 → $202 | $135.47 | +49.11% | 6 | Jan 17, 2025 | |
| NVCR NovoCure | Upgrades: Outperform | $18 → $30 | $16.24 | +84.73% | 11 | Dec 2, 2024 | |
| A Agilent Technologies | Maintains: In-Line | $145 → $142 | $103.68 | +36.96% | 3 | Nov 26, 2024 | |
| EXAS Exact Sciences | Maintains: Outperform | $80 → $60 | $43.43 | +38.17% | 3 | Nov 6, 2024 | |
| USB U.S. Bancorp | Maintains: In-Line | $51 → $54 | $39.10 | +38.13% | 4 | Oct 30, 2024 | |
| SYK Stryker | Maintains: Outperform | $380 → $384 | $347.45 | +10.52% | 9 | Oct 30, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $630 → $620 | $440.45 | +40.77% | 10 | Oct 24, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: In-Line | $475 → $490 | $488.03 | +0.40% | 11 | Oct 18, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Outperform | $19 → $25 | $11.89 | +110.26% | 7 | Oct 15, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: In-Line | $113 → $110 | $98.22 | +11.99% | 12 | Oct 1, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: In-Line | $335 → $355 | $323.74 | +9.66% | 8 | Oct 1, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $52 → $56 | $39.43 | +42.02% | 5 | Oct 1, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $120 → $160 | $112.90 | +41.72% | 7 | Oct 1, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $100 → $104 | $83.03 | +25.26% | 4 | Oct 1, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $98 → $102 | $63.05 | +61.78% | 3 | Oct 1, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $62 → $58 | $31.97 | +81.42% | 3 | Oct 1, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $275 → $278 | $190.28 | +46.10% | 2 | Oct 1, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $82 → $90 | $94.20 | -4.46% | 5 | Oct 1, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $286 → $290 | $202.77 | +43.02% | 6 | Oct 1, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $120 → $124 | $126.07 | -1.64% | 10 | Oct 1, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: In-Line | $4.5 → $5 | $2.97 | +68.35% | 3 | Aug 7, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $46 → $45 | $27.74 | +62.25% | 6 | Jul 2, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $28 → $27 | $15.23 | +77.34% | 10 | Jul 2, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $195 → $175 | $74.74 | +134.15% | 6 | Jun 11, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Outperform | $88 → $125 | $95.77 | +30.52% | 1 | Jan 4, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Outperform | $7 | $0.72 | +871.14% | 1 | May 31, 2022 |
Edwards Lifesciences
Feb 12, 2025
Maintains: In-Line
Price Target: $75 → $73
Current: $70.70
Upside: +3.26%
Mettler-Toledo International
Feb 10, 2025
Maintains: Outperform
Price Target: $1,450 → $1,475
Current: $1,055.50
Upside: +39.74%
Hologic
Feb 6, 2025
Maintains: In-Line
Price Target: $76 → $73
Current: $57.90
Upside: +26.08%
Azenta
Feb 6, 2025
Maintains: In-Line
Price Target: $50 → $52
Current: $26.62
Upside: +95.34%
J.B. Hunt Transport Services
Jan 17, 2025
Maintains: Outperform
Price Target: $207 → $202
Current: $135.47
Upside: +49.11%
NovoCure
Dec 2, 2024
Upgrades: Outperform
Price Target: $18 → $30
Current: $16.24
Upside: +84.73%
Agilent Technologies
Nov 26, 2024
Maintains: In-Line
Price Target: $145 → $142
Current: $103.68
Upside: +36.96%
Exact Sciences
Nov 6, 2024
Maintains: Outperform
Price Target: $80 → $60
Current: $43.43
Upside: +38.17%
U.S. Bancorp
Oct 30, 2024
Maintains: In-Line
Price Target: $51 → $54
Current: $39.10
Upside: +38.13%
Stryker
Oct 30, 2024
Maintains: Outperform
Price Target: $380 → $384
Current: $347.45
Upside: +10.52%
Oct 24, 2024
Maintains: Outperform
Price Target: $630 → $620
Current: $440.45
Upside: +40.77%
Oct 18, 2024
Maintains: In-Line
Price Target: $475 → $490
Current: $488.03
Upside: +0.40%
Oct 15, 2024
Upgrades: Outperform
Price Target: $19 → $25
Current: $11.89
Upside: +110.26%
Oct 1, 2024
Maintains: In-Line
Price Target: $113 → $110
Current: $98.22
Upside: +11.99%
Oct 1, 2024
Maintains: In-Line
Price Target: $335 → $355
Current: $323.74
Upside: +9.66%
Oct 1, 2024
Maintains: Outperform
Price Target: $52 → $56
Current: $39.43
Upside: +42.02%
Oct 1, 2024
Maintains: Outperform
Price Target: $120 → $160
Current: $112.90
Upside: +41.72%
Oct 1, 2024
Maintains: Outperform
Price Target: $100 → $104
Current: $83.03
Upside: +25.26%
Oct 1, 2024
Maintains: Outperform
Price Target: $98 → $102
Current: $63.05
Upside: +61.78%
Oct 1, 2024
Maintains: Outperform
Price Target: $62 → $58
Current: $31.97
Upside: +81.42%
Oct 1, 2024
Maintains: Outperform
Price Target: $275 → $278
Current: $190.28
Upside: +46.10%
Oct 1, 2024
Maintains: Outperform
Price Target: $82 → $90
Current: $94.20
Upside: -4.46%
Oct 1, 2024
Maintains: Outperform
Price Target: $286 → $290
Current: $202.77
Upside: +43.02%
Oct 1, 2024
Maintains: Outperform
Price Target: $120 → $124
Current: $126.07
Upside: -1.64%
Aug 7, 2024
Maintains: In-Line
Price Target: $4.5 → $5
Current: $2.97
Upside: +68.35%
Jul 2, 2024
Maintains: Outperform
Price Target: $46 → $45
Current: $27.74
Upside: +62.25%
Jul 2, 2024
Maintains: Outperform
Price Target: $28 → $27
Current: $15.23
Upside: +77.34%
Jun 11, 2024
Maintains: Outperform
Price Target: $195 → $175
Current: $74.74
Upside: +134.15%
Jan 4, 2024
Upgrades: Outperform
Price Target: $88 → $125
Current: $95.77
Upside: +30.52%
May 31, 2022
Initiates: Outperform
Price Target: $7
Current: $0.72
Upside: +871.14%